OSU Wexner Medical Center to Participate in Coronavirus Vaccine Trial

OSU Wexner Medical Center

COLUMBUS, Ohio (WTVN)--The Ohio State University Wexner Medical Center will participate in a coronavirus vaccine trial.

Hospital officials say they will be conducting the study for the vaccine that is being developed by the University of Oxford and AstraZeneca.

Researchers plan to recruit 500 participants for the randomized, double-blind study to see how well it can protect people from COVID-19.

Study participants will receive either the experimental vaccine or a placebo, have blood samples drawn and follow up with medical experts over two years. The study seeks those at higher risk of exposure such as teachers, first responders, college students, factory workers, restaurant employees and those age 65 or older.

The vaccine's clinical trial, conducted in the UK, showed that it is safe, and produced both antibodies and T-cells.

Overall, the vaccine, known as AZD1222, will have 30,000 clinical trial participants.

Sponsored Content

Sponsored Content